ADARx Pharmaceuticals, Inc.
ADRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802369
In the last 90 days, ADARx Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by ADARx Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 3 filings
- 3 insiders, $44.4M in total
- Open-market sells
- 0 filings
- Insiders trading
- 3
- Net value
- +$44.4M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for ADARx Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Chimovits Erez | Director | 9,292,025Indirect | Sep 30, 2026 | 1 |
| Gordon Carl L | Director, 10% Owner | 588,235Indirect | Sep 30, 2026 | 1 |
| OrbiMed Advisors LLC | Director, 10% Owner | 588,235Indirect | Sep 30, 2026 | 1 |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | 588,235Indirect | Sep 30, 2026 | 1 |
| OrbiMed Advisors Israel II Ltd | Director, 10% Owner | 588,235Indirect | Sep 30, 2026 | 1 |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | 588,235Indirect | Sep 30, 2026 | 1 |
| OrbiMed Genesis GP LLC | Director, 10% Owner | 588,235Indirect | Sep 30, 2026 | 1 |
| Sr One Capital Management, LLC | 10% Owner | 592,593Indirect | Sep 29, 2026 | 1 |
| George Simeon | Director, 10% Owner | 592,593Indirect | Sep 29, 2026 | 1 |
| LAV Biosciences Fund V, L.P. | 10% Owner | 307,738Indirect | Sep 29, 2026 | 1 |
| LAV Fund VI Opportunities, L.P. | 10% Owner | 307,738Indirect | Sep 29, 2026 | 1 |
| LAV Fund VI, L.P. | 10% Owner | 307,738Indirect | Sep 29, 2026 | 1 |
| Zhu Rui (NMN) | Chief Technology Officer | – | Sep 28, 2026 | 1 |
| MacLeod Alan Robert | Chief Scientific Officer | – | Sep 28, 2026 | 1 |
| Fisk Ryan | CFO and CBO | – | Sep 28, 2026 | 1 |
| Li Zhen | President and CEO | – | Sep 28, 2026 | 1 |
| Ackles Robert William | Chief People Officer | – | Sep 28, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 (view filing)5:29 PM ET | Sep 28 | 2 days | Chimovits ErezDirector | PPurchase | +61.5K | $17.00 | +$1.05M | +0.7%9.29M after | |
| Sep 30, 2026 (view filing)5:25 PM ET | Sep 28 | 2 days | Gordon Carl LDirector, 10% Owner | PPurchase | +950.0K | $17.00 | +$16.1M | New position588.2K after | 3 lotsDuplicate filing |
| Sep 30, 2026 (view filing)5:23 PM ET | Sep 28 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +950.0K | $17.00 | +$16.1M | New position588.2K after | 3 lots |
| Sep 29, 2026 (view filing)9:45 PM ET | Sep 28 | 1 day | Sr One Capital Management, LLC10% Owner | PPurchase | +1.60M | $17.00 | +$27.2M | New position592.6K after | 3 lotsDuplicate filing |
| Sep 29, 2026 (view filing)9:43 PM ET | Sep 28 | 1 day | George SimeonDirector, 10% Owner | PPurchase | +1.60M | $17.00 | +$27.2M | New position592.6K after | 3 lots |